In the presence of GI AEs, one of the first precautions recommended is to extend the titration period or delay dose escalation until symptoms subside
I think that well see multiple studies from STEP-HFpEF, and well probably see it from SUMMIT as well, that weight loss is a major mechanism of benefit, but there probably is something else going on. This is going to affect how we think about the majority of patients with HFpEF
Orlistat A non-systemic lipase inhibitor, orlistat offers modest weight loss (~ 3%) and T2D prevention benefits, with a 45% reduction in incident T2D in the XENDOS trial [14]
Can I take Black cohosh and Glucosamine together
This potent weight loss medication improves metabolic health by lowering blood sugar, blood pressure, and cholesterol levels
This fundamental principle, sometimes called the energy balance equation, has guided obesity treatment for decades